Literature DB >> 2818562

Isolation of a human hepatic 60 kDa aspartylglucosaminidase consisting of three non-identical polypeptides.

M Baumann1, L Peltonen, P Aula, N Kalkkinen.   

Abstract

We have characterized the properties of human aspartylglucosaminidase (EC 3.5.1.26), the lysosomal enzyme which is deficient in the human inherited disease aspartylglucosaminuria. The purification procedure from human liver included affinity chromatography, gel filtration, strong-anion- and strong-cation-exchange h.p.l.c., chromatofocusing and reverse-phase h.p.l.c. In a denaturing SDS/polyacrylamide-gel electrophoresis, the 6600-fold purified enzyme was shown to be composed of three non-identical inactive polypeptide chains of molecular masses 24, 18 and 17 kDa. In a native polyacrylamide-gel electrophoresis, these polypeptide chains ran as one active enzyme complex. As judged from the elution position of the native enzyme in a Biogel P-100 gel filtration, the approximate molecular mass of this complex was 60 kDa. The enzyme had a pI of 5.7, a pH optimum at 6, of 0.48 mM and a specific activity of 200,000 nkat for the substrate 2-acetamido-1-beta-(L-aspartamido)-1,2-dideoxy-D-glucose. The enzyme showed a 57% loss of activity at 60 degrees C after 45 h but was practically inactive after incubation at 72 degrees C for a few minutes. The molecular structure, Km and specific activity as well as the thermostability of the enzyme described here are different from those reported previously for human aspartylglucosaminidase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818562      PMCID: PMC1133246          DOI: 10.1042/bj2620189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Structural determination of three glycoasparagines isolated from the urine of a patient with aspartylglycosaminuria.

Authors:  A Lundblad; P K Masson; N E Nordén
Journal:  Eur J Biochem       Date:  1976-08-01

2.  Isolation of the liver N-aspartyl-beta-glucosaminidase in aspartylglucosaminuria.

Authors:  H Savolainen
Journal:  Biochem J       Date:  1976-03-01       Impact factor: 3.857

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Purification and some properties of 1-aspartamido-beta-N-acetylglucosamine amidohydrolase from human liver.

Authors:  B Dugal; J Stromme
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

5.  Aspartylglycosaminuria. An inborn error of metabolism associated with mental defect.

Authors:  R J Pollitt; F A Jenner; H Merskey
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

6.  Glycoasparagine metabolites in patients with aspartylglycosaminuria: comparison between English and Finnish patients with special reference to storage materials.

Authors:  J Palo; R J Pollitt; K M Pretty; H Savolainen
Journal:  Clin Chim Acta       Date:  1973-08-17       Impact factor: 3.786

7.  Aspartylglucosaminuria. II. Biochemical studies on brain, liver, kidney and spleen.

Authors:  J Palo; P Riekkinen; A U Arstila; S Autio; T Kivimäki
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

8.  Electrophoretic concentration of macromolecules.

Authors:  W B Allington; A L Cordry; G A McCullough; D E Mitchell; J W Nelson
Journal:  Anal Biochem       Date:  1978-03       Impact factor: 3.365

9.  Measurement of 1-aspartamido-beta-N-acetylglucosamine amidohydrolase activity in human tissues.

Authors:  B Dugal
Journal:  Biochem J       Date:  1977-04-01       Impact factor: 3.857

10.  Distribution, purification and properties of 1-aspartamido-beta-N-acetylglucosamine amidohydrolase.

Authors:  J Conchie; I Strachan
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

View more
  8 in total

1.  Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure.

Authors:  R Halila; M Baumann; E Ikonen; N Enomaa; L Peltonen
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Comparison of liver glycosylasparaginases from six vertebrates.

Authors:  O K Tollersrud; N N Aronson
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts.

Authors:  N Enomaa; T Heiskanen; R Halila; R Sormunen; R Seppälä; M Vihinen; L Peltonen
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

4.  Purification and structure of human liver aspartylglucosaminidase.

Authors:  J W Rip; M B Coulter-Mackie; C A Rupar; B A Gordon
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

5.  Human leucocyte glycosylasparaginase is an alpha/beta-heterodimer of 19 kDa alpha-subunit and 17 and 18 kDa beta-subunit.

Authors:  O K Tollersrud; T Heiskanen; L Peltonen
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

6.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease.

Authors:  E Ikonen; M Baumann; K Grön; A C Syvänen; N Enomaa; R Halila; P Aula; L Peltonen
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

7.  Biochemical characterization and comparison of aspartylglucosaminidases secreted in venom of the parasitoid wasps Asobara tabida and Leptopilina heterotoma.

Authors:  Quentin Coulette; Séverine Lemauf; Dominique Colinet; Geneviève Prévost; Caroline Anselme; Marylène Poirié; Jean-Luc Gatti
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

8.  Lysosomal aspartylglucosaminidase is processed to the active subunit complex in the endoplasmic reticulum.

Authors:  E Ikonen; I Julkunen; O K Tollersrud; N Kalkkinen; L Peltonen
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.